[
  {
    "report_key": "2026:q1",
    "period_label": "2026 Q1",
    "date": "2026-05-27",
    "title": "Kvartalsrapport Q1 2026",
    "original_title": "SynAct Pharma publicerar delårsrapport Q1 2026",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b4dbd3f271989f587de7c9243c1fc78e8&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
        "title": "Kvartalsrapport Q1 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aef628bb051762f152807cda4a5c133c9",
        "date": "2026-05-27",
        "period": "2026-q1",
        "form_type": "interim-report",
        "report_key": "2026:q1",
        "filename": "SynAct_Pharma_Q1_2026_Delarsrapport.pdf",
        "text_chars": 89833,
        "sha256": "2e857f4d02c1d3a9483800a2d9b775729fff9fed9ee497f0973f7e87322e4b97",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
            "chars": 89833
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:annual",
    "period_label": "2025 Årsredovisning",
    "date": "2026-04-15",
    "title": "Årsredovisning 2025",
    "original_title": "SynAct Pharma publicerar årsredovisning för 2025",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b6a5a1ede73128c3217fb82c7e1b9a1cf&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2025,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2025",
        "title": "Årsredovisning 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a459e70f487d42df785c6bb5c7faf489a",
        "date": "2026-04-15",
        "period": "2025-annual",
        "form_type": "annual-report",
        "report_key": "2025:annual",
        "filename": "SynAct_Pharma_AB_Arsredovisning_2025.pdf",
        "text_chars": 285170,
        "sha256": "990b1b3dd10a421ca68244074ce2aef48d441b54944c9d912f57803bcc3c6e91",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2025",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2025",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
            "chars": 179057
          },
          {
            "number": 2,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
            "chars": 106111
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q4",
    "period_label": "2025 Q4",
    "date": "2026-02-18",
    "title": "Kvartalsrapport Q4 2025",
    "original_title": "SynAct Pharma bokslutskommuniké för 2025",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bc31286864fea797564f598cedd475419&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2025,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
        "title": "Kvartalsrapport Q4 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aacfe3c91766da9d853ef2d782fed5c73",
        "date": "2026-02-18",
        "period": "2025-q4",
        "form_type": "year-end-report",
        "report_key": "2025:q4",
        "filename": "SynAct_Pharma_Q4_2025_Delarsrapport.pdf",
        "text_chars": 90669,
        "sha256": "2b486bd51ce23ff281f5af5b5a73213867292be738267531cfc10cf2bf1f5de1",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
            "chars": 90669
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q3",
    "period_label": "2025 Q3",
    "date": "2025-10-30",
    "title": "Kvartalsrapport Q3 2025",
    "original_title": "SynAct Pharma publicerar delårsrapport Q3 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b7b6fd4c4508279a30ae185e81bf1b6b5&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
        "title": "Kvartalsrapport Q3 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a9aa6754168c9d211bb79cf0bd9ea3c4e",
        "date": "2025-10-30",
        "period": "2025-q3",
        "form_type": "interim-report",
        "report_key": "2025:q3",
        "filename": "SynAct_Pharma_Q3_2025_Delarsrapport.pdf",
        "text_chars": 89961,
        "sha256": "334a266722ca6536cd1fa365a15bbb2bae489b22f558e145500792e705e29151",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
            "chars": 89961
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q2",
    "period_label": "2025 Q2",
    "date": "2025-08-20",
    "title": "Kvartalsrapport Q2 2025",
    "original_title": "SynAct Pharma publicerar delårsrapport Q2 2025",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b90dc6f2e84323bd7f31e7974e18f0898&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
        "title": "Kvartalsrapport Q2 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/abb85308bea260d076ba2c5c4f3950960",
        "date": "2025-08-20",
        "period": "2025-q2",
        "form_type": "interim-report",
        "report_key": "2025:q2",
        "filename": "SynAct_Pharma_Q2_2025_Delarsrapport.pdf",
        "text_chars": 85186,
        "sha256": "89acc586725d0dc585547f14d032093321e136369e5576f1b9bdb89a7d394660",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
            "chars": 85186
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q1",
    "period_label": "2025 Q1",
    "date": "2025-05-27",
    "title": "Kvartalsrapport Q1 2025",
    "original_title": "SynAct Pharma publicerar delårsrapport Q1 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=ba8ac9ab3446edc51940e263080806c03&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
        "title": "Kvartalsrapport Q1 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/af03394fd18f44f9f7460b90bb573c281",
        "date": "2025-05-27",
        "period": "2025-q1",
        "form_type": "interim-report",
        "report_key": "2025:q1",
        "filename": "SynAct_Pharma_Q1_2025_Delarsrapport.pdf",
        "text_chars": 79745,
        "sha256": "f7fbf9bd26e12ccbb00005fd5f31a781c88390c9b399700675a1767f6b0fb6a2",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
            "chars": 79745
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:annual",
    "period_label": "2024 Årsredovisning",
    "date": "2025-04-10",
    "title": "Årsredovisning 2024",
    "original_title": "SynAct Pharma publicerar årsredovisning för 2024",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b1214e81951fde15c9da3d2bcf8be9b16&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2024,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2024",
        "title": "Årsredovisning 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a55291ac91810d4e6b483d2b5b3ff628e",
        "date": "2025-04-10",
        "period": "2024-annual",
        "form_type": "annual-report",
        "report_key": "2024:annual",
        "filename": "SynAct_Pharma_AB_Arsredovisning_2024.pdf",
        "text_chars": 280555,
        "sha256": "ce15cb2f11cde6b84bb7906187c0d60655e366a6916d188b4d0af5be1d3756ed",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2024",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2024",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
            "chars": 179972
          },
          {
            "number": 2,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
            "chars": 100581
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q4",
    "period_label": "2024 Q4",
    "date": "2025-02-18",
    "title": "Kvartalsrapport Q4 2024",
    "original_title": "SynAct Pharma bokslutskommuniké för 2024",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bd249300c7365a92e6482feeacfdc0cab&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2024,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
        "title": "Kvartalsrapport Q4 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a7244d301ff63415f15fa946cdc137082",
        "date": "2025-02-18",
        "period": "2024-q4",
        "form_type": "year-end-report",
        "report_key": "2024:q4",
        "filename": "SynAct_Pharma_Q4_2024_Delarsrapport.pdf",
        "text_chars": 77354,
        "sha256": "569b64ec4f7fc3bfe36417d573ad58a3909b9b3e69986e46c391cdd9eeb7a0fd",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
            "chars": 77354
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q3",
    "period_label": "2024 Q3",
    "date": "2024-10-30",
    "title": "Kvartalsrapport Q3 2024",
    "original_title": "SynAct Pharma publicerar delårsrapport Q3 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b97d88d92d29c13e7aa9b3d7bf24d8e25&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
        "title": "Kvartalsrapport Q3 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a624caea2485d1f24373c8eeaaa8a03be",
        "date": "2024-10-30",
        "period": "2024-q3",
        "form_type": "interim-report",
        "report_key": "2024:q3",
        "filename": "SynAct_Pharma_Q3_2024_Delarsrapport.pdf",
        "text_chars": 76160,
        "sha256": "7c8a711c3a4d3d8fa874537d61836642f5675e790a2499701709ecbc2640eba7",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
            "chars": 76160
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q2",
    "period_label": "2024 Q2",
    "date": "2024-08-20",
    "title": "Kvartalsrapport Q2 2024",
    "original_title": "SynAct Pharma publicerar delårsrapport Q2 2024",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b1d9932af6f1a16016e700cfcd7b14f9e&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
        "title": "Kvartalsrapport Q2 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a9661055a47fa9fd0ca97f5c3119534ca",
        "date": "2024-08-20",
        "period": "2024-q2",
        "form_type": "interim-report",
        "report_key": "2024:q2",
        "filename": "SynAct_Pharma_Q2_2024_Delarsrapport.pdf",
        "text_chars": 69351,
        "sha256": "fa27f4242fb3a44034232792f64bf5f3afb3870e46a9daf45c4abca310838a00",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
            "chars": 69351
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q1",
    "period_label": "2024 Q1",
    "date": "2024-05-31",
    "title": "Kvartalsrapport Q1 2024",
    "original_title": "SynAct Pharma publicerar delårsrapport Q1 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bddb5d73bca5448c9b63d6c335290d7db&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
        "title": "Kvartalsrapport Q1 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aaf75ad2e30ba61a9470d9cf567dd8be5",
        "date": "2024-05-31",
        "period": "2024-q1",
        "form_type": "interim-report",
        "report_key": "2024:q1",
        "filename": "SynAct_Pharma_Q1_2024_Delarsrapport.pdf",
        "text_chars": 68803,
        "sha256": "913da495e5a30426e81fae77abcf35d33ce3b31cb011c79aacef0a522670f8f2",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
            "chars": 68803
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:annual",
    "period_label": "2023 Årsredovisning",
    "date": "2024-03-26",
    "title": "Årsredovisning 2023",
    "original_title": "SynAct Pharma publicerar årsredovisning för 2023",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b65e28271844cd29144b0e0f323241a74&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2023,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2023",
        "title": "Årsredovisning 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a1ec65c58dae6cb556634909826df1f8f",
        "date": "2024-03-26",
        "period": "2023-annual",
        "form_type": "annual-report",
        "report_key": "2023:annual",
        "filename": "SynAct_Pharma_AB_Arsredovisning_2023.pdf",
        "text_chars": 293672,
        "sha256": "9b266db204f6a3f046d1e162c09a076f94e134618085bb805c9248e197fe3732",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2023",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2023",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
            "chars": 179635
          },
          {
            "number": 2,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
            "chars": 114035
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q4",
    "period_label": "2023 Q4",
    "date": "2024-02-23",
    "title": "Kvartalsrapport Q4 2023",
    "original_title": "SynAct Pharma AB (publ) (”SynAct”) publicerar idag delårsrapport för det fjärde kvartalet och helåret 2023.",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b01eef9f2d05259bf2fb87a11839d9a60&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2023,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
        "title": "Kvartalsrapport Q4 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a9cf323e4ab27f6b24e4e9b52cd7e85c4",
        "date": "2024-02-23",
        "period": "2023-q4",
        "form_type": "year-end-report",
        "report_key": "2023:q4",
        "filename": "SynAct_Pharma_Q4_2023_Delarsrapport.pdf",
        "text_chars": 79563,
        "sha256": "2ab48236d6bcfe24afc35c6544ae3ec7a6b4d2926f084c562312dc86e60efd2c",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
            "chars": 79563
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q3",
    "period_label": "2023 Q3",
    "date": "2023-10-24",
    "title": "Kvartalsrapport Q3 2023",
    "original_title": "SynAct Pharma publicerar delårsrapport Q3 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b1daab32671cfe3955a09678f5a63dc50&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
        "title": "Kvartalsrapport Q3 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a2addd2988ae7f74674ece98ee7708eff",
        "date": "2023-10-24",
        "period": "2023-q3",
        "form_type": "interim-report",
        "report_key": "2023:q3",
        "filename": "SynAct_Pharma_Q3_2023_Delarsrapport.pdf",
        "text_chars": 81241,
        "sha256": "55926ab9c1a78796f8773eced3b263b36a0e3f208958fc49f33948407ae5e0f9",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
            "chars": 81241
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q2",
    "period_label": "2023 Q2",
    "date": "2023-08-04",
    "title": "Kvartalsrapport Q2 2023",
    "original_title": "SynAct Pharma publicerar delårsrapport Q2 2023",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bbffe932055b30853e88c42b74068e2fa&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
        "title": "Kvartalsrapport Q2 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a997d2060d116c6cafbe787ec40bc9d78",
        "date": "2023-08-04",
        "period": "2023-q2",
        "form_type": "interim-report",
        "report_key": "2023:q2",
        "filename": "SynAct_Pharma_Q2_2023_Delarsrapport.pdf",
        "text_chars": 79425,
        "sha256": "f701b6dbdd4b13f3b5dc1caa01bfe0b81692fa88b8e68849f05ab2bc51a70c1b",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
            "chars": 79425
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q1",
    "period_label": "2023 Q1",
    "date": "2023-05-05",
    "title": "Kvartalsrapport Q1 2023",
    "original_title": "SynAct Pharma publicerar delårsrapport Q1 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b5d5fd93f70f6245f363ac48eb576df2c&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
        "title": "Kvartalsrapport Q1 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a567fdc9793be18c6b909ff87e1934bf6",
        "date": "2023-05-05",
        "period": "2023-q1",
        "form_type": "interim-report",
        "report_key": "2023:q1",
        "filename": "SynAct_Pharma_Q1_2023_Delarsrapport.pdf",
        "text_chars": 82787,
        "sha256": "57add4595e5fa405563d3c5e30f444197bdef62aeb4b8ba1fc6cd3f6f6e78407",
        "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "absolute_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "txt_url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
            "chars": 82787
          }
        ]
      }
    ],
    "alternatives": []
  }
]